These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2696500)

  • 21. Is the carboxyl-terminus of dystrophin required for membrane association? A novel, severe case of Duchenne muscular dystrophy.
    Hoffman EP; Garcia CA; Chamberlain JS; Angelini C; Lupski JR; Fenwick R
    Ann Neurol; 1991 Oct; 30(4):605-10. PubMed ID: 1789686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of dystrophin c-DNA for the direct diagnosis of Duchenne muscular dystrophy in female carriers].
    Baiget M; del Río E; Gallano P
    Neurologia; 1989 Oct; 4(8):268-76. PubMed ID: 2576910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and clinical correlations of Xp21 muscular dystrophy.
    Bushby KM
    J Inherit Metab Dis; 1992; 15(4):551-64. PubMed ID: 1528016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RFLP for Duchenne muscular dystrophy cDNA clone 44-1.
    Laing NG; Siddique T; Bartlett RJ; Yamaoka LH; Chen JC; Walker AP; Hung WY; Roses AD
    Nucleic Acids Res; 1988 Jul; 16(14B):7209. PubMed ID: 2900496
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical and molecular studies in Duchenne muscular dystrophy.
    Emery AE
    Prog Clin Biol Res; 1989; 306():15-28. PubMed ID: 2662210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quadriceps myopathy: forme fruste of Becker muscular dystrophy.
    Sunohara N; Arahata K; Hoffman EP; Yamada H; Nishimiya J; Arikawa E; Kaido M; Nonaka I; Sugita H
    Ann Neurol; 1990 Nov; 28(5):634-9. PubMed ID: 2260849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA.
    Darras BT; Koenig M; Kunkel LM; Francke U
    Am J Med Genet; 1988 Mar; 29(3):713-26. PubMed ID: 2897793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dystrophin and Duchenne muscular dystrophy: distinguished neuroscientists review the recent revolutionary discoveries of molecular biology.
    Brumback RA; Bodensteiner JB
    J Child Neurol; 1989 Oct; 4(4):238-9. PubMed ID: 2677112
    [No Abstract]   [Full Text] [Related]  

  • 29. Duchenne muscular dystrophy. Localizing the gene product.
    Beam KG
    Nature; 1988 Jun; 333(6176):798-9. PubMed ID: 3290681
    [No Abstract]   [Full Text] [Related]  

  • 30. Deletions in the dystrophin gene: analysis of Duchenne and Becker muscular dystrophy patients in Quebec.
    Simard LR; Gingras F; Delvoye N; Vanasse M; Melançon SB; Labuda D
    Hum Genet; 1992 Jun; 89(4):419-24. PubMed ID: 1618490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The difference between Duchenne and Becker dystrophies.
    Fischbeck KH
    Neurology; 1989 Apr; 39(4):584-5. PubMed ID: 2648189
    [No Abstract]   [Full Text] [Related]  

  • 32. [Muscular dystrophy].
    Tsukahara T; Ishiura S; Arahata K; Sugita H
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1246-53. PubMed ID: 2192396
    [No Abstract]   [Full Text] [Related]  

  • 33. [Membrane changes in Duchenne/Becker muscular dystrophy: lectin binding and localization of dystrophin].
    Voit T; Patel K; Sewry CA; Strong PN; Dubowitz V; Dunn MJ
    Monatsschr Kinderheilkd; 1989 Jan; 137(1):20-7. PubMed ID: 2646527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MspI RFLP for Duchenne muscular dystrophy cDNA subclone 9.
    Wagner M; Reiss J; Hentemann M; Thies U
    Nucleic Acids Res; 1989 Apr; 17(8):3328. PubMed ID: 2471152
    [No Abstract]   [Full Text] [Related]  

  • 35. Dystrophin: a clinical perspective.
    Wessel HB
    Pediatr Neurol; 1990; 6(1):3-12. PubMed ID: 2178617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Wellcome lecture, 1988. Muscular dystrophy: a time of hope.
    Kunkel LM
    Proc R Soc Lond B Biol Sci; 1989 Jun; 237(1286):1-9. PubMed ID: 2569197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino-terminal deletion of 53% of dystrophin results in an intermediate Duchenne-Becker muscular dystrophy phenotype.
    Takeshima Y; Nishio H; Narita N; Wada H; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
    Neurology; 1994 Sep; 44(9):1648-51. PubMed ID: 7936290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular pathology of Duchenne and Becker muscular dystrophy].
    Gilgenkrantz H; Chelly J; Récan D; Chafey P; Kaplan JC
    C R Seances Soc Biol Fil; 1992; 186(4):349-53. PubMed ID: 1301222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective dystrophin in Duchenne and Becker dystrophy myotubes in cell culture.
    Sklar RM; Beggs AH; Lev AA; Specht L; Shapiro F; Brown RH
    Neurology; 1990 Dec; 40(12):1854-8. PubMed ID: 1701042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Difference of new mutation rates in dystrophin gene between deletion and duplication mutation in Duchenne and Becker muscular dystrophy].
    Kawamura J; Kato S; Ishihara T; Hiraishi Y; Kawashiro T
    Rinsho Shinkeigaku; 1997 Mar; 37(3):212-7. PubMed ID: 9217419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.